Decentralized Clinical Trials: Helping Improve Efficiency in Clinical Research

In today’s clinical research environment, decentralized clinical trials have become a necessity rather than an option. The pressures to improve trial efficiency, reach more diverse patient populations and maintain participant engagement have accelerated the shift from traditional models to more flexible and patient-centric approaches. However, successfully transitioning to decentralized clinical trials requires a set of essential capabilities that go beyond basic technology adoption.

This webinar will explore how pharmaceutical companies and clinical research organizations (CROs) can embrace these critical elements to stay competitive and meet evolving regulatory demands. Key topics will include the role of real-world data (RWD) in supporting patient recruitment, diversity action plans and trial site selection. The expert speaker will discuss how RWD not only facilitates recruitment but also helps design trials that meet US Food and Drug Administration (FDA)’s diversity guidelines, ensuring that therapies are effective across various demographics.

Additionally, the webinar will highlight the logistical challenges and solutions for decentralized models, such as mobile phlebotomy, remote monitoring and seamless integration with lab testing infrastructure. Maintaining data integrity while enabling remote participation is critical to ensuring trial success. The speaker will thus share strategies for navigating these challenges while maintaining compliance with FDA guidelines and ensuring operational efficiency.

Finally, they will examine patient engagement, a key element of successful decentralized clinical trials. Engaging participants throughout the trial — especially those in remote or underserved areas — ensures retention and adherence, both of which are vital for gathering accurate data.

Register for this webinar today to gain actionable insights and practical strategies in the rapidly evolving world of clinical research and ensure successful trial execution with decentralized clinical trials.

Speaker

Chaarles Fogelgren, Executive Director, BioPharma Services, Quest Diagnostics

Chaarles Fogelgren is an accomplished executive with extensive experience in the biopharmaceutical and life sciences industries. Currently serving as Executive Director of Biopharma Services at Quest Diagnostics, Chaarles plays a critical role leading Quest’s critical role in supporting clinical trials by leveraging Quest’s comprehensive lab testing capabilities, real-world data insights and decentralized trial solutions. His expertise helps pharmaceutical companies advance drug development and improve patient outcomes.

Prior to Quest, Chaarles served as VP and General Manager at med fusion, where he led the creation of a new clinical trials business. Prior to that, he led Global Lab Data Management at Quintiles Central Labs and led the Drug Development business at Southern Research, gaining a deep understanding of drug development, clinical trial design and operations. He started his career supporting US Government national security programs focused on developing countermeasures to biological weapons and bioterrorism.

Chaarles earned his undergraduate degree from The George Washington University in Washington, DC, and later earned his MBA from the Kenan-Flagler Business School at the University of North Carolina – Chapel Hill. Throughout his career, Charles has been recognized for his vision and innovative approach to clinical research.

Message Presenter